In the latest episode of Health Law Diagnosed, host Bridgette Keller discusses the new Massachusetts Health Care Market Review Law and what this means for health care providers, investors, and other key stakeholders. She is joined by Member Deborah Daccord, Of Counsel, Cassie Paolillo, and Of Counsel Kate Stewart, who share their insights on the law’s far-reaching implications, including: 1. An overview of the Massachusetts Health Care Review Law and its implications 2. Key takeaways for health care entities 3. Upcoming HPC guidance and how it will affect health care transactions 4. Expanded oversight and new authorities for Massachusetts health care agencies 5. Financial assessments for health care entities 6. Regulatory considerations and potential delays for health care transactions Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.

In the latest episode of Health Law Diagnosed, host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon. Have questions or want to connect with the team? Reach out to us at healthlawdiagnosed@mintz.com.

The 2024 Election and Health Care Policy by Mintz

In the latest episode of Health Law Diagnosed – Women Leaders in Health Care, a series that brings together women leaders for discussions on timely key issues and reflections on developing a career in the industry, host Bridgette Keller leads a conversation around investing in women's health. She is joined by Lauren Edgerton, Healthcare Director at Piper Sandler, and Kathryne Cooper, Partner at Jumpstart Nova. Lauren and Kathryne discuss the areas of women's health that have seen the most growth in the last few years, how they evaluate a potential investment including their standard criteria, and how you can get involved in investing in women's health care. Our guests also cover topics such as: • What are the unique challenges in raising capital for companies that focus on women's health? • Why do you think women’s health has historically been underfunded compared to other sectors, and what can be done to improve funding for women’s health? • What advice would you give to women interested in a career in investing in health care?

In the latest episode of Health Law Diagnosed – Women Leaders in Health Care, a series that brings together women leaders for discussions on timely key issues and reflections on developing a career in the industry, host Bridgette Keller leads a conversation around the emerging role of artificial intelligence (AI) in health care. She is joined by Jane Moran, Chief Information and Digital Officer at Mass General Brigham, Rebecca Mishuris, Chief Medical Information Officer and VP at Mass General Brigham, and Carina Edwards, Chief Executive Officer at Kipu Health. They discuss the opportunities for enhanced patient-provider interactions and improvements in health care delivery through the use of AI. They delve into how this powerful technology can alleviate administrative burdens by helping with tasks like clinician documentation to streamline workflow, determining evidence-based treatment plans, improving revenue cycle processes, and developing patient acquisition and engagement models. Our guests also explore the future of AI in health care, covering topics such as: • How do we deploy this technology to improve what matters while maintaining safety, data privacy, ethics, and transparency? • How do we use AI to deliver higher quality, equitable care? • How do we make AI a true inflection point in health care delivery and how patients receive it? Jane, Rebecca, and Carina also share thoughtful advice for women looking to have a career in health IT, including tips on: • Leaning into obtaining experience with new AI technology • Working on gaining a seat at the table • Raising your hand for things you want on your career path • Finding a sponsor – women are over-mentored and under-sponsored • Following your passion and curiosity • Networking strategically

In this episode of Health Law Diagnosed, host Bridgette Keller is joined by Mintz Health Law attorneys Joanne Hawana and Benjamin Zegarelli to discuss the FDA’s long-awaited proposed rules that actively regulate laboratory developed tests (LDTs). LDTs have historically not been subject to significant regulatory oversight, and while the FDA aims to promptly release the final rule on this intricate issue laden with complexities, potential roadblocks may delay its course of action. Bridgette, Joanne, and Ben discuss this and also cover: • What is a laboratory developed test (LDT) • Where LDTs sit from a regulatory perspective • What industry stakeholders are saying about these rules • What the proposed rules mean • Why the FDA is stepping in now

As the Mintz Health Law team welcomes the beginning of 2024, many of its members take a moment to reflect on the exciting growth of the Health Law Practice, opportunities to partner with clients on complex legal issues, and the celebration of numerous milestones.